Metabolic Complications of Glucocorticoids – Prevention by Metformin

May 2023 in “ Annales d'Endocrinologie ”

Kanokporn Sanpawithayakul, Márta Korbonits

Studysummary In this study, researchers found that metformin improved glycaemic control and other metabolic parameters in non-diabetic patients on glucocorticoid treatment, also reducing pneumonia risk and hospital admissions, suggesting a potential advantage for routine use in this population.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

We don't know much about this study yet.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Impaired Metabolic Effects of Metformin in Men with Early-Onset Androgenic Alopecia

4 citations , December 2021 in “Pharmacological Reports”

This study found that metformin's metabolic benefits, such as reducing fat content and improving insulin sensitivity, were less pronounced in men with early-onset androgenic alopecia compared to those with normal hair growth, possibly due to differences in systemic inflammation and vitamin D status.

research Impact of Metformin and Rosiglitazone Treatment on Glucose Transporter 4 mRNA Expression in Women with Polycystic Ovary Syndrome

40 citations , April 2008 in “European journal of endocrinology”

In this study, treatment with insulin sensitizers significantly increased adipose tissue GLUT4 mRNA expression and improved insulin resistance, menstrual patterns, and androgen profiles in PCOS patients, with rosiglitazone being more effective than metformin.